Firms

Founded

—

Type

Venture capital

Team

No team members on record yet.

Co-investing

RA Capital Management

• Ollin$330M · 2026-06-24
• Ollin Biosciences$330M · 2026
• Nimbus Therapeutics$105M · 2021-07-13

ARCH Venture Partners

• Ollin$330M · 2026-06-24
• Ollin Biosciences$330M · 2026

BVF Partners L.P.

• Immunic$60M · 2022-10-10
• Nimbus Therapeutics$105M · 2021-07-13

Canada Pension Plan Investment Board

• Ollin$330M · 2026-06-24
• Ollin Biosciences$330M · 2026

Great Point Partners

• Neurogene$200M · 2024-11-04
• Immunic$60M · 2022-10-10

SHOW MORE

Investments

$330M2026-06-24	Ollin	ARCH Venture Partners, T. Rowe Price, Mubadala Ventures, RA Capital Management, Canada Pension Plan Investment Board, Commodore Capital
$120M2026-03-17	Alto Neuroscience	Commodore Capital, Perceptive Advisors, Venrock Healthcare Capital Partners
$330M2026	Ollin Biosciences	ARCH Venture Partners, T. Rowe Price, Mubadala Ventures, RA Capital Management, Canada Pension Plan Investment Board, Commodore Capital
$50M2025-10-21	Alto Neuroscience	Perceptive Advisors, Commodore Capital, Vivo Capital
$200M2024-11-04	Neurogene	RTW Investments, LP, Casdin Capital, EcoR1 Capital, Redmile Group, Commodore Capital, Samsara BioCapital, Great Point Partners
$60M2022-10-10	Immunic	Deep Track Capital, Commodore Capital, BVF Partners L.P., RTW Investments, LP, Great Point Partners, Logos Capital, Vivo Capital, The Invus Group, LLC
$105M2021-07-13	Nimbus Therapeutics	BVF Partners L.P., RA Capital Management, Atlas Venture, Access Biotechnology, Commodore Capital, Logos Capital, Surveyor Capital

SHOW MORE